What is trastuzumab?
Trastuzumab belongs to targeted (biological) therapy, which blocks the growth and spread of cancer. They target as well as interfere with processes in the cells that are believed to help cancer grow. Patients may have a brand of trastuzumab injection named Herceptin, or may have a biosimilar.
Mechanism of Action?
Some breast cancer cells contain a higher than normal level of HER2 protein on their surface, which is involved in stimulating them in order to grow.
Around 1 in 5 invasive breast cancers have this and are known as HER2 +Ve.
Trastuzumab acts in order to attach itself to HER2 proteins so that the cancerous cells are no longer stimulated to grow. It also benefits the immune system to destroy breast cancer cells.
Who might be offered trastuzumab?
Only individuals with HER2 +Ve breast cancer will benefit from trastuzumab. In case your cancer is HER2 -Ve, then this medication will not be of any sort of benefit.
There are multiple tests in order to measure the level of HER2, performed on breast tissue eliminated during a biopsy/surgery.
The HER2 testing is basically only performed on invasive breast cancer, so it’s unlikely to be mentioned in case you've an early form of breast cancer named ductal carcinoma in situ (DCIS).
Trastuzumab 440 mg injection may not be useful for individuals with heart complications or hypertension that’s not well controlled. In case your breast cancer is HER2 +Ve and you have heart complications, your doctor will usually perform additional tests in order to check how effectively your heart is functioning.
When is trastuzumab given:
The trastuzumab injection can be used as a treatment of certain conditions, listed as follows:
- Primary breast cancer
- Breast cancer recurrence
- Secondary breast cancer
- Fever
- Chills
- Mild pain
- Nausea
- Diarrhoea
- Soreness at the injection site
- Headaches
- Dizziness
- Joint and muscle pain
- Rash
- Vomiting (being sick)
- Breathlessness
- Afinitor (Everolimus)
- Aredia (Pamidronate Disodium)
- Arimidex (Anastrozole)
- Aromasin (Exemestane)
- Ellence (Epirubicin Hydrochloride)
- 5-FU (Fluorouracil Injection)
- Fareston (Toremifene)
- Faslodex (Fulvestrant)
- Femara (Letrozole)
- Gemzar (Gemcitabine Hydrochloride)
- Halaven (Eribulin Mesylate)
- Ibrance (Palbociclib 125mg)
- Infugem (Gemcitabine Hydrochloride)
- Ixempra (Ixabepilone)
- Kadcyla (Ado-Trastuzumab Emtansine)
- Keytruda (Pembrolizumab)
- Kisqali (Ribociclib)
- Lynparza (Olaparib)
- Margenza (Margetuximab-cmkb)
- Nerlynx (Neratinib Maleate)
- Perjeta (Pertuzumab)
- Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf)
- Piqray (Alpelisib)
- Soltamox (Tamoxifen Citrate)
- Talzenna (Talazoparib Tosylate)
- Taxotere (Docetaxel)
- Tecentriq (Atezolizumab)
- Tepadina (Thiotepa 15mg)
- Trexall (Methotrexate Sodium)
- Tykerb (Lapatinib Ditosylate)
- Verzenio (Abemaciclib)
- Xeloda (Capecitabine)
- Zoladex (Goserelin Acetate)
- Being female
- Obesity
- Lack of exercise, alcohol
- Hormone replacement therapy during menopause
- Ionizing radiation
- Early age at first menstruation
- Having babies later in the phase of life or not at all.
- Older age
- Prior breast cancer
- Family history of breast cancer
- Klinefelter syndrome
- Painless lumps in the breast.
- Thickening of the breast.
- Nipple or breast skin change, such as redness, dimpling, or puckering.
- Discharge of fluid from the nipples.
This comment has been removed by a blog administrator.
ReplyDelete